Position in DNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$772,355
-$730,933 QoQ
Shares Held
77,937
-70.4% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 183 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Mar 31, 2022CallValue
$0
CallShares
220,120
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. DNA ranks #197 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in DNA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $772,355 | 77,937 | Shares | Other | 2026-08-13 | |
| 2025-03-31 | $1,503,288 | 263,735 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $664,656 | 67,684 | Shares | Other | 2025-02-13 | |
| 2024-03-31 | $631,575 | 544,462 | Shares | Other | 2024-05-15 | |
| 2022-06-30 | $922,292 | 387,518 | Shares | Other | 2022-08-15 | |
| 2022-03-31 DNABW | — | 220,120 | Call | Other | 2022-05-16 | |
| 2022-03-31 | $5,088,781 | 1,262,725 | Shares | Other | 2022-05-16 | |
| 2021-12-31 DNABW | — | 199,996 | Call | Other | 2022-02-14 | |
| 2021-12-31 | $899,623 | 108,258 | Shares | Other | 2022-02-14 | |
| 2021-09-30 DNABW | — | 199,996 | Call | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||